June 17, 2025 a 08:00 am
RMD: Fundamental Ratio Analysis - ResMed Inc.
ResMed Inc. is a strong player in the healthcare sector, specifically in medical devices and cloud-based software. Its financial health reflects a balanced approach, with strengths in technology and software for healthcare. The company's market presence in over 140 countries adds significant value to its stock performance.
Fundamental Rating
The fundamental rating reflects a decent standing, with a few areas needing attention. The Debt-to-Equity and Price-to-Book ratios are aspects to keep an eye on for future growth.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
The historical data shows stable scores with slight variations, indicating consistent performance over the period under review.
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-16 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 2 | 2 | 1 |
Analyst Price Targets
Analyst targets show a strong upside potential, with a high target of 286 and consensus at a stable 265, reflecting confidence in future growth.
| High | Low | Median | Consensus |
|---|---|---|---|
| 286 | 240 | 265 | 265 |
Analyst Sentiment
The analyst sentiment leans towards a strong buy and buy recommendations, indicating positive anticipation around the stock.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 12 | |
| Sell | 5 | |
| Strong Sell | 0 |
Conclusion
ResMed Inc. represents a promising investment given its strong market position and comprehensive product offerings. While there are areas like Debt-to-Equity that need improvement, the overall outlook remains positive with significant growth potential. Analyst sentiments and price targets further reinforce the optimistic outlook, making it a worthwhile consideration for investors seeking exposure in healthcare technology.